Dixon Mark J, Nathubhai Amit, Andersen Ole A, van Aalten Daan M F, Eggleston Ian M
Wolfson Laboratory of Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA27AY, UK.
Org Biomol Chem. 2009 Jan 21;7(2):259-68. doi: 10.1039/b815077j. Epub 2008 Nov 13.
A new, highly efficient, all-solid-phase synthesis of argifin, a natural product cyclic pentapeptide chitinase inhibitor, is reported. The synthesis features attachment of an orthogonally protected Asp residue to the solid support and assembly of the linear peptide chain by Fmoc SPPS prior to cyclisation and side-chain manipulation on-resin. Introduction of the key N-methyl carbamoyl-substituted Arg side chain is achieved via derivatisation of a selectively protected Orn residue, prior to cleavage from the resin and side-chain deprotection. A severe aspartimide side-reaction observed upon final deprotection is circumvented by the use of a novel aqueous acidolysis procedure. The flexibility of the synthesis is demonstrated by the preparation of a series of argifin analogues designed from the X-ray structure of the natural product in complex with a representative family 18 chitinase.
报道了一种新型、高效的全固相合成方法,用于合成天然产物环状五肽几丁质酶抑制剂阿吉芬。该合成方法的特点是将一个正交保护的天冬氨酸残基连接到固相载体上,并在环化和树脂上侧链操作之前,通过Fmoc固相肽合成法组装线性肽链。关键的N-甲基氨基甲酰基取代的精氨酸侧链是通过对一个选择性保护的鸟氨酸残基进行衍生化引入的,然后从树脂上裂解并进行侧链脱保护。通过使用一种新型的酸解水溶液程序,避免了在最终脱保护时观察到的严重天冬氨酸亚胺副反应。通过从天然产物与代表性的18家族几丁质酶复合物的X射线结构设计一系列阿吉芬类似物,证明了该合成方法的灵活性。